Doctor profile · Federal record
Dr. Matthew Clark, MD
Dermatology Physician (CMS: Dermatology) · Internal Medicine Physician · Rochester, MI
- NPI 1902288806
- Accepts Medicare
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1000 W University Dr Ste 314
Rochester, MI 483071876
(248) 375-4033
fax (248) 375-4034
Credentials & registration
- NPI registered
- June 2015 — 11 yrs on file
- Profile last updated
- February 22, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Michigan #4301500350 · Michigan #4301108372
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902288806. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,026
Distinct HCPCS
10
Medicare allowed
$73,354
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 259 | 59 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 168 | 142 | $85 | |
11102 |
Biopsy of related skin growth, first growth | 96 | 89 | $86 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 93 | 93 | $106 | |
17000 |
Destruction of precancer skin growth, 1 growth | 86 | 72 | $48 | |
17110 |
Destruction of skin growth, 1-14 growths | 86 | 74 | $103 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | 11 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 35 | 28 | $120 | |
11103 |
Biopsy of related skin growth, each additional growth | 32 | 21 | $47 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 32 | 30 | $274 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 64. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$1,240
Transactions
76
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 13 | $262.10 | |
| Novartis Pharmaceuticals Corporation | 26 | $185.17 | |
| ABBVIE INC. | 9 | $143.92 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102.98 | |
| UCB, Inc. | 3 | $77.47 | |
| Arcutis Biotherapeutics, Inc. | 4 | $75.49 | |
| LEO Pharma Inc. | 3 | $59.36 | |
| Amgen Inc. | 2 | $53.55 | |
| PFIZER INC. | 3 | $50.78 | |
| GENZYME CORPORATION | 2 | $41.32 | |
| Lilly USA, LLC | 2 | $40.75 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $37.92 | |
| Incyte Corporation | 1 | $27.70 | |
| Dermavant Sciences, Inc. | 1 | $24.07 | |
| Genentech USA, Inc. | 1 | $19.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
500
Patients
322
Total drug cost
$13,749
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 84 | 46 | $2,037 |
| Triamcinolone Acetonide | Generic | 80 | 64 | $684 |
| Clobetasol Propionate | Generic | 78 | 51 | $1,346 |
| Doxycycline Hyclate | Generic | 41 | 25 | $907 |
| Clindamycin Phosphate | Generic | 35 | 19 | $1,860 |
| Fluocinonide | Generic | 33 | 19 | $1,452 |
| Mupirocin | Generic | 27 | 23 | $177 |
| Cephalexin | Generic | 19 | 16 | $321 |
| Tacrolimus | Generic | 19 | 12 | $2,829 |
| Ammonium Lactate | Generic | 15 | 11 | $208 |
Frequently asked questions
What is Dr. Matthew Clark's medical specialty?
Dr. Matthew Clark practices Dermatology Physician in Rochester, MI.
Where does Dr. Matthew Clark practice?
Dr. Matthew Clark practices at 1000 W University Dr Ste 314, Rochester, MI 483071876. Office phone: 2483754033.
What is Dr. Matthew Clark's NPI?
Dr. Matthew Clark's National Provider Identifier (NPI) is 1902288806, issued by NPPES.
Does Dr. Matthew Clark accept Medicare assignment?
Yes. Dr. Matthew Clark accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Clark commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.